The U.S.-China Health Products Association was invited by the China’s National People’s Congress Legislative Department to discuss China's Draft Food Safety Law.
Discussions revolved around support for the Designer Anabolic Steroid Control Act of 2014, as well as arguments against the Dietary Supplement Labeling Act.
Keep claims simple and write them in a manner that assumes your product helps to support a normal structure/function of the body, rather than trying to correct an abnormal condition.
As anticipated, Senator Richard Durbin, D-Ill., has reintroduced the Dietary Supplement Labeling Act, to which APHA and CRN have voiced serious concerns.
CRN and the NPA have met with the entire freshman class of the 113th Congress as part of their educational efforts to ensure that newly elected members of Congress have accurate information about dietary supplements.
More than two-thirds of healthcare practitioners agreed that dietary supplements and/or natural products can treat or ameliorate diseases and conditions.